Insights

Strategic Collaborations Dyno is actively expanding its AI-native biology capabilities through high-profile partnerships, including collaborations with NVIDIA to accelerate therapeutic design workflows. This indicates readiness to engage with suppliers of AI tooling, cloud services, and computational biology platforms to support joint development programs.

AI Platform Growth Recent launches of Dyno Psi-Phi and an open-source agentic protein design suite, plus a curated SDI dataset release, signal a strong emphasis on AI-driven design. This opens opportunities to offer specialized AI/ML services, data annotation, model optimization, and cloud-based compute partnerships.

New Capids and Therapies Introduction of two new AAV capsids and muscle-targeted vectors (Dyno-bn8) at industry gatherings suggests ongoing product expansion and target diversification, presenting chances to pitch manufacturing support, regulatory consulting, and supply chain services for gene therapy vectors.

Open Data & Community Dyno’s open data initiatives and community-driven data releases create potential collaborations for platform licensing, data integration, and ecosystem partnerships with biotech service providers seeking to leverage broader datasets for model training and validation.

Scale Readiness With revenue in the tens of millions and a healthy funding base, Dyno appears poised for scale-up collaborations, including services for clinical trial support, advanced analytics, and AI-enabled workflow tooling that can improve design-to-decision timelines for gene therapy programs.

Similar companies to Dyno Therapeutics

Dyno Therapeutics Tech Stack

Dyno Therapeutics uses 8 technology products and services including LinkedIn Recruiter, GitHub, Kubernetes, and more. Explore Dyno Therapeutics's tech stack below.

Media & News

Dyno Therapeutics's Email Address Formats

Dyno Therapeutics uses at least 3 email formats:
Dyno Therapeutics Email FormatsExamplePercentage
First.Last@dynotx.comJohn.Doe@dynotx.com
97%
FL@dynotx.comJD@dynotx.com
2%
LF@dynotx.comDJ@dynotx.com
1%

Frequently Asked Questions

What is Dyno Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Dyno Therapeutics's official website is dynotx.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Dyno Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2026, Dyno Therapeutics's annual revenue is estimated to be $50M - $100M.

What is Dyno Therapeutics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Dyno Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dyno Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2026, Dyno Therapeutics has approximately 94 employees across 2 continents, including North America and Europe. Key team members include Co-Founder & Scientific Advisor: T. B., Executive Chairman: A. C. and Director, Engineering: D. L. Explore Dyno Therapeutics's employee directory with LeadIQ.

What industry does Dyno Therapeutics belong to?

Minus sign iconPlus sign icon
Dyno Therapeutics operates in the Biotechnology Research industry.

What technology does Dyno Therapeutics use?

Minus sign iconPlus sign icon
Dyno Therapeutics's tech stack includes LinkedIn Recruiter, GitHub, Kubernetes, WordPress, Atlassian Jira, Sentry, Notion and Microsoft Azure.

What is Dyno Therapeutics's email format?

Minus sign iconPlus sign icon
Dyno Therapeutics's email format typically follows the pattern of First.Last@dynotx.com. Find more Dyno Therapeutics email formats with LeadIQ.

How much funding has Dyno Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2026, Dyno Therapeutics has raised $109M in funding. The last funding round occurred on May 06, 2021 for $100M.

When was Dyno Therapeutics founded?

Minus sign iconPlus sign icon
Dyno Therapeutics was founded in 2018.
Dyno Therapeutics logo

Dyno Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Dyno Therapeutics is a mid-sized biotechnology company based in Watertown, Massachusetts. It develops advanced genetic technologies with the goal of improving patient outcomes. Operating in the biotechnology research sector, the company focuses on expanding the capabilities used in genetic therapy research.

Its activities are oriented toward the biotechnology research community pursuing gene therapies and related areas. In May 2026, Dyno Therapeutics announced a development at the ASGCT Annual Meeting intended to support rare-disease therapeutic development.

Section iconCompany Overview

Website
dynotx.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $109M

    Dyno Therapeutics has raised a total of $109M of funding over 3 rounds. Their latest funding round was raised on May 06, 2021 in the amount of $100M as a Series A.

  • $50M - $100M

    Dyno Therapeutics's revenue is estimated to be in the range of $50M - $100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.